Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Gynaecology
  4. Back
  5. Gynaecology guidelines
  6. Ascitic Drain Insertion And Management in Gynaecology (1077)
Announcements and latest updates

Right Decision Service newsletter: October 2024

Welcome to the Right Decision Service (RDS) newsletter for October 2024.

1.Contingency arrangements for RDS outages

Development of the contingency solutions to maximise RDS resilience and minimise risk of future outages is in progress, aiming for completion by Christmas. As a reminder, these contingency arrangements  are:

  • Optimising mobile app build process
  • Mobile app always to be downloadable.
  • Serialising builds to mobile app; separate mobile app build from other editorial and end-user processes
  • Load balancing – provides failover (also enables separation of editorial processes from other processes to improve performance.)

 

In the meantime, a gentle reminder to encourage users to download essential clinical toolkits to their mobile devices so that there is an offline version always available.

 

2. New deployment with improvements.

A new scheduled deployment with minor improvements drawn from support tickets, externally funded projects, information related to outages, and feature requests will take place in early December. Key improvements planned are:

  • Deep-linking to individual toolkits within the RDS mobile app. Each toolkit will now have its own direct URL and QR code, both accessible from the app. These can be used to download the toolkit directly where users already have the RDS app installed. If the user does not yet have the RDS app installed, they will be taken to the app store to install the app and immediately afterwards the toolkit will automatically open and download. Note that this will go live a few days later than the improvements below due to the need to link up the mobile front end to the changes in the content management system.
  • Introducing an Announcement Header field to replace the hardcoded "Announcements and latest updates" text. This will enable users to see at a glance the focus of new announcements.
  • Automated daily emptying of the recycling bin (with a 30 day rolling grace period)  in the content management system. A bug preventing complete emptying of the recycling bin contributed to one of the outages earlier this year.
  • Supporting multiple passcodes (ticket 6079)
  • Expanding accordion section to show location of a search result rather than requiring user coming from a search result to manually open all sections and search again for the term.
  • Displaying first accordion section Content text as a snippet on the search results page as a fallback if default/main content is not provided
  • Displaying the context of each search result in the form of a link to the relevant parent tool/section. This will help users to choose which search result is most likely to be appropriate for their needs.
  • As part of release of the new national benzodiazepine quality prescribing guidance toolkit sponsored by Scottish Government Effective Prescribing and Therapeutics, a digital tool to support creation of benzodiazepine tapering/withdrawal schedules.

We are also seeking approval to use the NHS Scotland logo and title for the RDS app on the app stores to help with audience engagement and clarity around the provenance of RDS.

3. RDS Search, Browse and Archive/Version control enhancements

We are still hopeful that user acceptance testing for at least the Search and browse enhancements can take place before Christmas. Thank you for your patience and understanding in waiting for these improvements. Timescales have been pushed back by old app migration challenges, work to address outages, and most recently implementing the contingency arrangements.

4. Support tickets

We are aware that there continue to be some issues around a number of RDS support tickets, in part due to constraints around visibility for the RDS team of the tickets in the existing  support portal. We are investigating the potential to move to a new support ticket requesting system from early in the new year. We will organise the proposed webinar around support ticket processes once we have confirmed the way forward with the system.

Table formatting

There is a known issue with alterations in formatting of some RDS tables which seems to have arisen as a result of the 17 October deployment. Tactuum is working on a fix and on implementing additional regression testing to prevent this issue recurring.

5. New RDS toolkits

Recently launched toolkits include:

NHS Lothian Infectious Diseases

Scottish Health Technologies Group – Technology Assessment recommendations

NHS Tayside Anaesthetics and Critical Care projects – an innovative toolkit which uses PowerAutomate to manage review and response to proposals for improvement projects.

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

A number of toolkits are expected to go live before Christmas, including:

  • Focus on dementia
  • Highland Council Getting it Right for Every Child
  • Dumfries and Galloway Adult Support and Protection procedures
  • National Waiting Well toolkit
  • Fertility Scotland National Network
  • NHS Lothian postural care for care homes

6.Sign up to RDS Editors Teams channel

We have had a good response to the recent invitation to sign up to the new Teams channel for RDS editors. This provides a forum for editors to share learning, ideas and questions and we hope to hold regular webinars on topics of interest.  The RDS team is in the process of joining participants to the channel and we’d encourage all editors to take part, using the registration form – available in Providers section of the RDS Learning and Support area.

 

7. Evaluation projects

The RDS team has worked with colleagues in NHS Grampian and the Digital Health & Care Innovation Centre to evaluate the impact of the Prevent the progress of diabetes web and mobile app in a small-scale pilot project. This app provides access to local and national resources and services targeted at people with prediabetes, a history of gestational diabetes, or candidates for remission. After just 8 weeks of using the app, 94% of patients reported increased their knowledge and understanding of diabetes, and 88% said it had increased their confidence and motivation to make lifestyle changes, highlighting specific behaviour changes. The learning from this project is informing development of a service model based on tailored support for patient groups with, high, medium and low digital self-efficacy.

Please contact ann.wales3@nhs.scot if you would like to know more about this project.

  1. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 29th November 3-4 pm
  • Thursday 5 December 3.30 -4.30 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

The Right Decision Service:  the national decision support platform for Scotland’s health and care

Website: https://rightdecisions.scot.nhs.uk    Mobile app download:  Apple  Android

 

 

Ascitic Drain Insertion And Management in Gynaecology (1077)

Warning

Objectives

To describe the indications, procedure and monitoring required for the safe insertion of Ascitic Drains in gynaecology including post insertion monitoring

Scope

Women attending with Ascites to Gynaecology where management with Paracentesis Drain is considered

Audience

All healthcare professionals involved in the care of women with ascites who require insertion of Ascitic drain in the gynaecology setting

Please report any inaccuracies or issues with this guideline using our online form

Malignant ascites is the accumulation of fluid within the peritoneal cavity of the abdomen secondary to cancer (an exudate not a transudate). Within gynaecology, ascites is most commonly associated with those suffering with ovarian malignancy. Approximately 60% of patients with advanced ovarian cancer develop ascites necessitating hospital admission and treatment.

The symptoms associated with ascites can be distressing for the patient including abdominal distension and pain, breathlessness, nausea, vomiting, early satiety, constipation and peripheral oedema.  These can greatly impact on patients’ quality of life. 

The principle for management of malignant ascites should be aimed at symptomatic relief and improvement of quality of life. For most patients, paracentesis is the treatment of choice and relieves symptoms in up to 90% patients. It is most likely to relieve symptoms of abdominal distension/discomfort and dyspnoea, however less likely to improve the associated symptoms of peripheral oedema, fatigue and poor mobility.

Paracentesis is a simple procedure to remove ascitic fluid from the abdominal cavity, which can be performed as a day case or as an inpatient. Removal of 4–6 litres is usually enough to give symptomatic relief. Removal of more than 4-6 litres increases the risk of hypovolemia and adverse effects, but may give symptomatic relief for longer until the ascites re-accumulates.   

Paracentesis may not be appropriate if the prognosis is very short and the patient is rapidly deteriorating. 

Indications for drainage of ascites by abdominal paracentesis

  1. As a diagnostic procedure to determine the cause of ascites and ascertain cytological diagnosis. It should be kept in mind there are other causes of ascites other than malignancy. It can be helpful to also send ascites to microbiology and biochemistry. It can be useful to have a serum to-ascites Albumin Gradient (SAAG) if the ascites turns out not to be malignant.
  2. As a therapeutic procedure: in patients with large volume ascites to provide symptomatic relief.

Contraindications

  • Severe bowel distension
  • Severe coagulopathy
  • Disseminated intravascular coagulation
  • Local or systemic infection
  • Low white cell count / neutropenia
  • Skin infection at the proposed puncture site 
  • Distressed/uncooperative patient

Risks with Paracentesis

The risk associated with paracentesis can be associated with the removal of large volumes (> 6 litres) as this can cause a ‘fluid shift’ with resultant hypovolaemia and hypotension, leading to symptoms of dizziness, fatigue and malaise. Additional procedural risks include; perforation of abdominal viscus, haemorrhage, infection, discomfort. See appendix 1 for risks to be discussed with patient when consenting for procedure.

Ultrasound imaging (USS)

Drain insertion should be performed under ultrasound guidance or following marking.  Care should be taken particularly if ascitic fluid is not easily clinically identified, there has been difficulty with previous paracentesis, there is suspected loculation of ascites or there are concerns about bowel obstruction.  Consideration should be given to assistance from radiology department where difficulty is anticipated.

Pre-procedure

  • Review up to date FBC, coag, U+Es and LFTs
  • Check IV access sited and patent
  • Ensure site has been marked if USS guidance not available
  • Ensure nursing staff available to assist insertion
  • Obtain informed consent
  • Patient should empty bladder prior to procedure
  • Check full set of observations including – pulse, BP, temperature, respiratory rate and O2 saturations
  • Ensure correct equipment available – see appendix 2 for required equipment

Procedure

  • Place patient in semi upright position
  • Confirm the presence of ascites
  • The usual site for paracentesis is the left side but can be in either iliac fossa at least 10cm from midline or suprapubically (must ensure bladder is empty). The chosen site should avoid: distended bowel or bladder and inferior epigastric arteries. Guided by ultrasound marking if trained.

  • Abdomen is prepared with aseptic solution and sterile drape applied
  • Infiltrate up to 10ml of 2% lidocaine into the area to be cannulated.
  • Using local anaesthetic syringe, needle is inserted through sheath and ascites withdrawn. A larger needle may need to be considered in patients with a high BMI
  • When anaesthesia of insertion site achieved small incision made with scalpel and drain needle inserted. Once flashback is visualised, advance the catheter whilst withdrawing the needle.
  • If cytology required minimum 200ml should be sent
  • It can be useful to consider sending fluid to microbiology and biochemistry, particularly where the ascites turns out not to be malignant. Tests should include  Cell count and differential, Bacterial culture, Albumin (for serum-to-ascites albumin gradient (SAAG)), Total protein, Glucose and LDH.
  • Closed drainage system is attached.
  • If drain is to remain in situ sutures are inserted and sterile dressing applied.
  • Document the procedure, plan for drainage and required frequency of observation in the notes.
  • Record full set of observations again and volume drained immediately post procedure

Post insertion management of paracentesis drain

  • Record BP, pulse and temperature every 15 minutes for the first hour after insertion, hourly for 4hrs and 4 hourly thereafter if within normal limits
  • Monitor fluid balance and urea and electrolytes daily Observe paracentesis insertion site and change dressing daily.
  • If the patient becomes unwell, clamp the drain, take pulse, blood pressure and temperature and seek medical advice.
  • Aim to remove drain after 48hrs. If continuing to drain significant volumes discuss with medical staff regarding timing of removal

Drainage rate and amount

Most patients will tolerate the procedure well. Total amount drained will depend on the individual patient, the volume of ascites and previous experiences with paracentesis. 

Patient group

Rate

Fluids

Systolic BP >100

No relevant co-morbidites

Drain 1L every 2-4hrs

Max 6L in 24hrs

Not usually required

Systolic BP <100 prior to or during drainage

Cardiovascular or renal comorbidities (at medical staff instruction)

Drain 1L every 4hrs

Max 6L in 24hrs

If BP drops significantly or symptoms of hypovolaemia* - stop drainage and seek medical advice

Consider fluid replacement with IV crystalloid

*Signs and symptoms of hypovolaemia: high pulse, low BP; dizziness; increasing fatigue and malaise.

The drain should be clamped after each litre drained and removed once minimal volumes draining. If significant volumes still draining at 48hrs discuss with senior medical staff regarding keeping the drain in situ for ongoing drainage, this should be reviewed by a senior clinician every 24hrs.

For patients where chemotherapy is unlikely to be effective and who require repeated drainage, an indwelling catheter should be considered and should be discussed with the oncology team.

Editorial Information

Last reviewed: 23/03/2023

Next review date: 31/03/2028

Author(s): Dr Morton Hair, Consultant Gynaecologist.

Version: 1

Approved By: Gynaecology Clinical Governance Group

Document Id: 1077